Inflammatory Astrocytes In Als is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
This page provides comprehensive information about the cell type. See the content below for detailed information.
Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic profile that promotes inflammation and fails to provide necessary support to motor neurons.
- Hypertrophic cell bodies
- Increased GFAP expression
- Proliferation in spinal cord and motor cortex
- Association with motor neuron loss
- GFAP - Upregulated intermediate filament
- C3 - Complement component C3 (A1 marker)
- Serpina3n - Acute phase protein
- Lcn2 - Lipocalin-2 (pro-inflammatory)
- Cxcl10 - Chemokine (IP-10)
- Complement components - C1q, C3 mediate synapse elimination
- Pro-inflammatory cytokines - IL-1β, TNF-α, IL-6
- Chemokines - CXCL10 recruits immune cells
- Excitotoxins - Dysregulated glutamate transport
- Reduced glutamate clearance (GLT-1 downregulation)
- Impaired potassium buffering
- Decreased metabolic support
- Reduced neurotrophic factor secretion
- Most common form (~90-95% of cases)
- Reactive astrocytes cluster around remaining motor neurons
- Variable A1/A2 polarization
- SOD1 mutations: Strong astrocyte involvement
- C9orf72 expansion: DPR toxicity in astrocytes
- FUS mutations: RNA metabolism disruption
- TDP-43 pathology: Ubiquitin dysfunction
- Direct contact with motor neurons
- Extracellular vesicle communication
- Metabolic coupling disruption
- Calcium signaling dysregulation
- Anti-inflammatory drugs - Minocycline, NSAIDs
- Astrocyte reprogramming - Converting to neuroprotective phenotype
- GLT-1 enhancement - Ceftriaxone (failed in trials)
- Growth factor delivery - GDNF, BDNF
- AAV-based astrocyte targeting
- CRISPR correction in familial cases
- Antisense oligonucleotides
The study of Inflammatory Astrocytes In Als has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Liddelow SA, et al. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature.
- Diaz-Amarilla P, et al. (2011). Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited ALS. PNAS.
- Re DB, et al. (2014). Necroptosis of motor neurons in ALS. Nature Neuroscience.